Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile
Table 4
Haplotype frequencies and comparison between Crohn’s patients with L1 ileum location, responders and nonresponders to infliximab therapy, in the chromosomal regions including (a) S100A9 and S100A8 genes (rs11205276, rs3014866, rs724781, and rs3006488); (b) G0S2 gene (rs4844486, rs1473683); (c) TNFAIP6 gene (rs11677200, rs2342910, rs3755480, and rs10432475); and (d) IL11 gene (rs1126760, rs1042506).